Delta 9 Cannabis (DN) Stock Price, News & Analysis

Company Overview

Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$0.01 to C$0.01
• 52-Week Range: N/A
• Volume: 1.07 million shs
• Average Volume: 813,175 shs
• Market Capitalization: C$3.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DN Stock Analysis - Frequently Asked Questions

How do I buy shares of Delta 9 Cannabis?

Shares of DN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Delta 9 Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Delta 9 Cannabis investors own include Baytex Energy (BTE), Delta 9 Cannabis (NINE), CrowdStrike (CRWD), Orefinders Resources (ORX), Albemarle (ALB), Delta 9 Cannabis (DLTNF) and VanEck Gold Miners ETF (GDX).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:DN
• CUSIP: N/A
• CIK: N/A
• Web: www.delta9.ca
• Phone: 855-245-1259
• Fax: N/A
• Employees: 200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-19,600,000.00
• Net Margins: -27.74%
• Pretax Margin: N/A
• Return on Equity: -29,673.63%
• Return on Assets: -12.08%

Debt

• Debt-to-Equity Ratio: 2,156.19
• Current Ratio: 0.30
• Quick Ratio: 0.14

Sales & Book Value

• Annual Sales: C$70.65 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.47
• Book Value: C($0.04) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 302,180,000
• Free Float: N/A
• Market Cap: C$3.02 million
• Optionable: Not Optionable
• Beta: 1.21